SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001599298-21-000036
Filing Date
2021-11-15
Accepted
2021-11-15 08:46:23
Documents
59
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q smmt-20210930.htm   iXBRL 10-Q 1021169
2 EX-31.1 sum-ex311_2021930x10q1.htm EX-31.1 12088
3 EX-32.1 sum-ex321_2021930x10q1.htm EX-32.1 6860
  Complete submission text file 0001599298-21-000036.txt   4522150

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT smmt-20210930.xsd EX-101.SCH 38406
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT smmt-20210930_cal.xml EX-101.CAL 49927
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT smmt-20210930_def.xml EX-101.DEF 129128
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT smmt-20210930_lab.xml EX-101.LAB 415126
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT smmt-20210930_pre.xml EX-101.PRE 274129
9 EXTRACTED XBRL INSTANCE DOCUMENT smmt-20210930_htm.xml XML 658783
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-514-7149
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36866 | Film No.: 211406650
SIC: 2834 Pharmaceutical Preparations